• Nem Talált Eredményt

1 SUPPLEMENTARY DATA Nicotinic acid suppresses sebaceous lipogenesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA

N/A
N/A
Protected

Academic year: 2022

Ossza meg "1 SUPPLEMENTARY DATA Nicotinic acid suppresses sebaceous lipogenesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA"

Copied!
5
0
0

Teljes szövegt

(1)

SUPPLEMENTARY DATA

Nicotinic acid suppresses sebaceous lipogenesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA2)

Arnold Markovics1, Kinga Fanni Tóth1, Katalin Eszter Sós1,2, József Magi1, Adrienn Gyöngyösi3, Zoltán Benyó4, Christos C. Zouboulis5, Tamás Bíró6,7,#,*, Attila Oláh1#

#These authors contributed equally.

1Department of Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; 2Laboratory of Cerebral Cortex Research, Institute of Experimental Medicine Hungarian Academy of Sciences, Budapest, Hungary; 3Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; 4Institute of Clinical Experimental Research, Semmelweis University, Budapest, Hungary; 5Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Dessau, Germany; 6DE-MTA

“Lendület” Cellular Physiology Research Group, Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; 7HCEMM Ltd., Szeged, Hungary

*CORRESPONDING AUTHOR:

Tamás Bíró, MD, PhD, DSc; DE-MTA “Lendület” Cellular Physiology Research Group, Department of Immunology, Faculty of Medicine, University of Debrecen;

(2)

2 SUPPLEMENTARY FIGURES

Supplementary Figure S1 Up to 100 μM, NA does not influence viability of human sebocytes

MTT-assays. Viability of SZ95 sebocytes was monitored following 24- (A), 48- (B), and 72-hr (C) treatments. Results are expressed in the percentage of the vehicle control (100%, solid line) as mean±SEM of four independent determinations. Two additional experiments yielded similar results.

A B

C

Viability (control= 100%) 120 100 80 60 40 20 0

150

100

50

0

120 100 80 60 40 20 0

1 10 100

0

1 10 100

0 Viability (control= 100%)

Viability (control= 100%)

1 10 100

0

NA (μM): NA (μM):

NA (μM):

25 125

75

(3)

Supplementary Figure S2 Up to 100 μM, NA can be applied without the risk of cytotoxicity

Combined fluorescent DilC1(5)-SYTOX Green labeling. To monitor apoptotic and necrotic cell death, SZ95 sebocytes were treated as indicated for 24 (A) or 48 (B) hours.

Results are expressed in the percentage of the vehicle control (100%, solid line;

DilC1(5) apoptosis data) or in the percentage of the positive control (100%, solid line;

SYTOX Green necrosis data) as mean±SEM of four independent determinations. Two additional experiments yielded similar results. *** and ### mark significant (P<0.001 in both cases) differences compared to the vehicle control group. CCCP: carbonyl cyanide m-chlorophenyl hydrazone (1:200; apoptosis positive control); LB: lysis buffer (1:100; positive control for necrosis); NA: nicotinic acid.

A B

120 100 80 60 40 20 0

120 100 80 60 40 20 0

Control CCCP LB 1 10 100

***

###***

###

Fluorescence

Control CCCP LB 1 10 100

***

***

###

DilC1(5) (↓: apoptosis) SYTOX Green (↑: necrosis)

Fluorescence

DilC1(5) (↓: apoptosis) SYTOX Green (↑: necrosis)

NA (µM) NA (µM)

(4)

4

Supplementary Figure S3 NA exerts universal lipostatic effects

Nile Red assay. Lipostatic efficiency of NA was assessed following 48-hr treatments in the presence of AEA (A) or LA+T combination (B). Results are expressed in the percentage of the vehicle control (100%, solid line) as mean±SEM of four independent determinations. One additional experiment yielded similar results. ** and *** mark significant (P<0.01 and 0.001, respectively) differences, as indicated. AEA:

anandamide; LA: linoleic acid; NA: nicotinic acid; T: testosterone.

LA (μM):

T (μM): 1 1

100 100

NA (μM): 0 100

100

0 300

200

AEA (μM):

100

0 200

NA (μM): 0 100

30 30

A B

Fluorescence (control= 100%) Fluorescence (control= 100%)

50 150

50 150 250

***

**

(5)

Supplementary Figure S4 Neither AA, nor NA influence HCA2 expression in human sebocytes

Immunofluorescent labeling. HCA2 expression was assessed following the indicated 24- hr treatments. Following appropriate background subtraction (for details, see the Materials and methods section) data of the green channel were expressed in the percentage of the vehicle control, and presented as mean±SEM of N=15-16 cells in each group. A.U.: arbitrary units.

Fluorescence (A.U.;control= 100%)

0 20 40 60 80 100 120

AA (μM):

NA (μM): 0 100

50 0

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

aa Research Unit for General Medicine and Primary Health Care, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece; ab Department of

Town, Redox Laboratory, Department of Human Biology, Cape Town, South Africa; 1580 University of Central Florida College of Medicine, Burnett School of Biomedical Sciences, Orlando,

1 Developmental Endocrinology Research Group, School of Medicine, Dentistry &amp; Nursing, University of Glasgow, Glasgow G51 4TF, UK; 2 Office for Rare Conditions, Royal Hospital

1 Semmelweis University, Faculty of Health Sciences, Institute of Health Promotion and Clinical Methodology, Department of Family Care and Methodology, Hungary Head of

19 Norwegian Medicines Agency, Oslo, Norway, 20 Department of Pharmacy, University of Medicine, Tirana, Albania, 21 Syreon Research Institute, Budapest, Hungary, 22 Department of

CE connected to MS by a sheathless ESI interface is a promising combination to obtain good separation efficiency and detection versatility, however, to maintain the

1 University of Novi Sad, Faculty of Technical Sciences, Department of Graphic Engineering and Design, Novi Sad, Serbia.. 2 University of Novi Sad, Faculty of Technical

1 Department of Toxicology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania, 2 Faculty of Medicine, Pharmacy and Dental Medicine, Vasile Goldis Western